124 related articles for article (PubMed ID: 7412088)
1. [alpha-lipoprotein cholesterol and its variability in ischemic heart disease].
Nikul'cheva NG; Krivoruchenko IV; Bermiakova AS; Kukuĭ LM; Arkhipov OP
Kardiologiia; 1980 Aug; 20(8):15-20. PubMed ID: 7412088
[TBL] [Abstract][Full Text] [Related]
2. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
[TBL] [Abstract][Full Text] [Related]
3. [Lipoprotein spectrum and makeup of the individual classes in coronary arteriosclerosis with a varying lipid level in the blood plasma].
Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaia TI; Gadzhalova SI
Kardiologiia; 1980 May; 20(5):42-6. PubMed ID: 7392382
[No Abstract] [Full Text] [Related]
4. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
[TBL] [Abstract][Full Text] [Related]
5. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
6. [Lipid level in the blood, based on multiple study data, and the characteristics of the course of ischemic heart disease].
Krivoruchenko IV; Nikul'cheva NG; Kukuĭ LM; Bermiakova AS; Triufanov VF
Kardiologiia; 1979 Apr; 19(4):67-73. PubMed ID: 439611
[TBL] [Abstract][Full Text] [Related]
7. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
Herrmann W; Reuter W
Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
[No Abstract] [Full Text] [Related]
8. [New approaches to the evaluation of the cholesterol content of plasma lipoprotein fractions in normo- and hyperlipoproteinemias].
Suchkova SN; Titov VN; Kurchatova SA; Zadoia AA; Shal'nov AI
Kardiologiia; 1978 Jun; 18(6):29-36. PubMed ID: 209240
[TBL] [Abstract][Full Text] [Related]
9. [Surgical correction of hyperlipoproteinemia in patients with ischemic heart disease].
Klimov AN; Lebedev LV; Sedletskiĭ IuI; Triufanov VF; Nagornev VA
Kardiologiia; 1984 Feb; 24(2):21-4. PubMed ID: 6585597
[TBL] [Abstract][Full Text] [Related]
10. Lecithin: cholesterol acyl transfer rate and high density lipoprotein level in coronary artery disease.
Wallentin L; Moberg B
Atherosclerosis; 1982 Feb; 41(2-3):155-65. PubMed ID: 7066068
[No Abstract] [Full Text] [Related]
11. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
12. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
Hutt V; Klör HU; Wechsler JG; Ditschuneit H
J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
[TBL] [Abstract][Full Text] [Related]
13. [Data on repeated studies on the blood lipid levels in evaluating the severity of chronic ischemic heart disease].
Shipilova TV
Kardiologiia; 1983 Feb; 23(2):85-8. PubMed ID: 6842955
[TBL] [Abstract][Full Text] [Related]
14. High density lipoprotein and other lipoproteins in normolipidaemic and hypertriglyceridaemic (type IV) men with coronary artery disease.
Moberg B; Wallentin L
Eur J Clin Invest; 1981 Dec; 11(6):433-40. PubMed ID: 6800818
[TBL] [Abstract][Full Text] [Related]
15. Diet and high density lipoproteins.
Oster P; Schlierf G; Heuck CC; Hahn S; Szymanski H; Schellenberg B
Lipids; 1981 Feb; 16(2):93-7. PubMed ID: 7242273
[TBL] [Abstract][Full Text] [Related]
16. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
Bednarska-Makaruk M; Kuźmińska A; Chotkowska E; Kurjata P; Polakowska M; Broda G; Rywik S
Pol Arch Med Wewn; 1992 Mar; 87(3):149-56. PubMed ID: 1523145
[TBL] [Abstract][Full Text] [Related]
17. In vivo platelet activity and lipoprotein patterns in coronary artery disease.
Goubran F; Maklady F; Saad M; el-Ashry M
Wien Klin Wochenschr; 1986 Apr; 98(7):209-11. PubMed ID: 3705598
[TBL] [Abstract][Full Text] [Related]
18. [Significance of high-density lipoprotein cholesterol in the development of ischemic heart disease in diabetes mellitus patients].
Bodnar PN; Donish RM; Panasiukova OR
Probl Endokrinol (Mosk); 1984; 30(3):19-24. PubMed ID: 6739447
[TBL] [Abstract][Full Text] [Related]
19. Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.
Sale JK; Johnstone JH
Ann Clin Biochem; 1981 Mar; 18 (Pt 2)():71-5. PubMed ID: 7259072
[TBL] [Abstract][Full Text] [Related]
20. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
